Clinical trial
Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies
NCT03387514 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 8, 2018
- Completion date
- June 29, 2021
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma